MorphoSys AG (MOR)

MorphoSys AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	158.5	402.35	123.25	109.79	44.31
Short-Term Investments	524.26	504.82	870.42	980.52	228.19
Cash & Cash Equivalents	682.76	907.17	993.66	1,090	272.5
Cash Growth	-24.74%	-8.70%	-8.86%	300.11%	-24.09%
Receivables	33.59	104.08	78.14	85.51	16.69
Inventory	62.07	24.25	20.76	9.96	0.29
Other Current Assets	35.61	53.53	40.41	21.02	14.21
Total Current Assets	814.02	1,089	1,133	1,207	303.69
Property, Plant & Equipment	14.99	50.99	49.59	50.74	47.81
Long-Term Investments	3.55	5.35	0	196.59	99
Goodwill and Intangibles	1,186	1,243	1,174	70.99	9.11
Other Long-Term Assets	7.34	8.73	199.8	134.37	36.82
Total Long-Term Assets	1,212	1,308	1,423	452.7	192.75
Total Assets	2,026	2,397	2,556	1,660	496.44
Accounts Payable	109.8	157.27	188.08	128.55	57.04
Deferred Revenue	0	0	0	0	1.57
Current Debt	130.6	114.28	93.16	3.63	2.53
Other Current Liabilities	23.9	6.8	3.3	68.27	0.42
Total Current Liabilities	264.31	278.35	284.54	200.46	61.56
Long-Term Debt	1,678	1,946	2,003	831.07	40.04
Other Long-Term Liabilities	34.91	15.18	23.67	6.66	0.14
Total Long-Term Liabilities	1,713	1,961	2,027	837.73	40.18
Total Liabilities	1,977	2,240	2,311	1,038	101.74
Total Debt	1,809	2,060	2,096	834.71	42.57
Debt Growth	-12.21%	-1.72%	151.15%	1860.84%	59422.91%
Retained Earnings	-1,013.13	-823.41	-672.35	-157.89	-255.78
Comprehensive Income	88.44	115.33	52.76	2.21	-1.3
Shareholders' Equity	49.05	157.41	244.88	621.32	394.7
Net Cash / Debt	-1,125.89	-1,153.1	-1,102.66	255.61	229.94
Net Cash / Debt Growth	-	-	-	11.17%	-35.93%
Net Cash Per Share	-32.81	-33.76	-33.01	7.71	7.27
Working Capital	549.71	810.69	848.43	1,006	242.13
Book Value Per Share	0.36	1.15	1.83	4.78	3.12

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).